Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

NCT00782613 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been termination early due to financial contraints.

Conditions

Psoriasis

Interventions

DRUG: 4,4-dimethyl-benziso-2H-selenazine
DRUG: Placebo

Sponsor

Synvista Therapeutics, Inc